# Myoepithelial cells and the breast basement membrane

Source: https://onco.cc/terms/myoepithelial-cells-and-basement-membrane/  
OnCo record `myoepithelial-cells-and-basement-membrane` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Myoepithelial cells are living cells around normal breast ducts and acini; basement membrane is separate extracellular material outside them.

## Summary

These layers help organise normal breast structures and support pathological assessment of invasion. Their location, morphology, staining controls and diagnostic context matter more than a single positive or negative marker.

## Fields

- Kind: Term
- Last checked: 2026-11-10
- Also known as: myoepithelium; myoepithelial layer

## Notes

- Typical normal breast ducts and acini have luminal epithelial cells facing the lumen, an outer living myoepithelial layer, extracellular basement membrane and then stroma. Myoepithelial cells have contractile features that help move milk; they are not the chest muscle. Basement membrane contains matrix proteins such as laminins and type IV collagen, not living cells.
- Basement membrane beneath an epithelial structure differs from plasma membrane around one cell. Cell polarity describes different inward and outward organisation. Gudjonsson and colleagues' human-cell culture experiments showed that normal myoepithelial cells or laminin-1 could restore luminal orientation in collagen gels; this is model evidence about organisation, not a demonstrated cancer treatment.
- Myoepithelial immunohistochemistry is supporting evidence interpreted with morphology. p63 is nuclear; calponin and smooth muscle myosin heavy chain are cytoplasmic markers. Ask which cells stain, where they stain and whether technical controls work. A failed positive control undermines an apparently absent rim.
- Werling and colleagues found gaps around some noninvasive structures, stromal staining with muscle-associated markers and p63 staining in some carcinoma cells. Gusterson and colleagues found basement-membrane proteins in some invasive carcinomas. Neither marker absence nor protein presence alone proves the tissue boundary. Basal-like RNA features also do not establish myoepithelial ancestry.
- In Gusterson and colleagues' 1982 tissue study, laminin and type IV collagen were detected in normal breast, benign lesions and grade I invasive carcinomas but were absent from grade II and III infiltrating carcinomas in that study. That historical cohort does not make protein presence proof of an intact noninvasive boundary, or protein absence a universal grade rule.
- Werling and colleagues examined 85 breast lesions. In that series, at least focal p63 staining in tumour cells occurred in 11% of cases, while stromal myofibroblasts stained with smooth muscle myosin heavy chain in 8% and calponin in 76%. Some noninvasive structures had gaps. These assay- and cohort-specific observations explain why localisation and controls matter; they are not universal diagnostic accuracy estimates.
- CAP's morphology-based histological classification and supporting-marker assessment answer a tissue question. A schematic rim is neither an immunostain result nor a diagnosis; illustrated gaps or colours cannot establish invasion. Interpret the actual tissue architecture and appropriately controlled stains together.

## Sources

- Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.: https://pubmed.ncbi.nlm.nih.gov/11801722/
- Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.: https://pubmed.ncbi.nlm.nih.gov/12502930/
- Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.: https://pubmed.ncbi.nlm.nih.gov/6290045/
- A spatially resolved single-cell genomic atlas of the adult human breast.: https://pubmed.ncbi.nlm.nih.gov/37380767/
- CAP invasive breast protocol: histological type and supporting assessment: https://www.cap.org/wp-content/uploads/2026/06/Breast.Invasive.Res_4.11.0.0.REL_CAPCP.pdf?download=true

## Connected records

- terms: [Ductal carcinoma in situ (DCIS)](https://onco.cc/terms/dcis/), [Ducts, lobules and the terminal duct lobular unit](https://onco.cc/terms/terminal-duct-lobular-unit/), [H&E staining (haematoxylin and eosin)](https://onco.cc/terms/h-and-e-staining/)
- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Invasive breast carcinoma of no special type (invasive ductal carcinoma)](https://onco.cc/cancers/invasive-breast-carcinoma-no-special-type/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)

---
JSON: https://onco.cc/api/v1/entities/myoepithelial-cells-and-basement-membrane.json